Typically, the specialists will inform us what we already know. Ray Dalio, the founding father of Bridgewater Associates, has constructed a legendary fame in monetary circles, for taking his agency from a house enterprise in his two-bedroom condo to the worldwide hedge fund large, using over 1,500 individuals and managing greater than $138 billion in whole belongings. However when questioned on how he did it, or how at present’s traders can survive the continued pandemic disaster, his recommendation can sound downright abnormal.Dalio’s recommendation for investing throughout the pandemic might be summed up simply sufficient. First, he says to diversify the portfolio. Diversification means spreading out the chance, which in flip will cut back your losses ought to one – and even a number of – investments flip south. Second, Dalio tells us to not hassle attempting to ‘time the market.’ Even the professionals don’t normally get this proper, and Dalio says that merely shopping for right into a inventory you want, and holding it long run, is a greater technique then attempting to purchase in on the proper time. The inventory market is a dangerous place to place your cash, and Dalio understands that. His techniques for mitigating that danger are age-old – and have arguably introduced him nice success. Bearing this in thoughts, we determined to have a look at Bridgewater’s latest exercise for inspiration. Working three shares Dalio’s fund picked up throughout Q3 by way of TipRanks’ database, we discovered that the analyst group can be on board, as every sports activities a “Sturdy Purchase” consensus score.Baxter Worldwide (BAX)We’ll begin with Baxter Worldwide, a healthcare firm primarily based exterior of Chicago. Baxter produces medical gadgets and different merchandise for the therapy of acute and persistent situations, significantly blood, immune, and kidney ailments. The corporate markets primarily to healthcare professionals and establishments, relatively than the open market, and boasts over $11 billion in annual income.The corporate’s revenues by way of 2020 have been secure, and in-line with historic values. Baxter ended 2019 with a $3 billion quarter; that slipped to $2.72 billion 1Q20, however had risen steadily to $2.97 billion by 3Q20. The corporate pays out a modest dividend for traders, which at 24.5 cents per widespread share offers a yield of 1.3%.Dalio’s place in Baxter is a brand new one for him. His agency purchased up 124,701 shares of the inventory, a holding that’s price $9.73 million at present costs.5-star analyst Danielle Antalffy, of SVB Leerink, writes of Baxter, “[We] see BAX’s underlying fundamentals — accelerating gross sales development, significant margin growth — as unchanged. Some of the significant datapoints on this quarter was 6% peritoneal dialysis affected person development… nicely forward of the mid-single-digit long-term development outlook for the Renal enterprise that the Road is modeling. Because the COVID pressures start to raise, visibility into the long-term development drivers ought to enhance, and we’d anticipate the shares to maneuver meaningfully greater.”According to her bullish feedback, Antalffy charges BAX shares an Outperform (i.e. Purchase), and her $105 worth goal implies a 34% one-year upside potential. (To look at Antalffy’s observe file, click on right here)General, the analyst consensus score on Baxter is a Sturdy Purchase, primarily based on 12 critiques that embody 11 Buys towards only a single Maintain. The inventory is promoting for $78, and its $95 common worth goal counsel it has room for ~22% upside development in 2021. (See BAX inventory evaluation on TipRanks)CVS Well being Company (CVS)The following inventory is one other healthcare firm, however the place Baxter, above, markets to the skilled aspect of that sector, CVS goals squarely on the shopper healthcare market. This firm is greatest generally known as the CVS pharmacy chain, and is a staple of the retail scene. CVS shops provide a spread of dwelling healthcare and hygiene merchandise, together with fundamental groceries, pharmacy providers, and a few extra specialised prescription medical tools. The corporate has introduced in additional than $130 billion in annual revenues for the previous three years.CVS’ revenues confirmed a slight dip this yr, throughout Q2, when financial situations deteriorated, however shortly rebounded. The sequence of quarterly earnings in 2020, $66.7 billion, $65.3 billion, and $67.1 billion, present a gradual gross sales base, to be anticipated from a retailer dealing in merchandise primarily deemed important throughout the shutdown insurance policies. Q3 EPS got here in at $1.66, nicely forward of consensus expectations of $1.33.The dividend right here is 50 cents per share, and has been held regular at that stage for over three years now. The cost annualizes to $2, and provides a yield of two.7%.Dalio’s Bridgewater purchased 320,039 shares of CVS inventory final quarter, increasing a check place that the agency already held. The purchase boosted the whole holding dramatically, to 333,804 shares, which at the moment are price $24.87 million.Deutsche Financial institution analyst George Hill notes that CVS appears to be like set for a ‘peaceable transition of energy’ when the present CEO, Larry Merlo, steps down subsequent yr. “Whereas we consider Ms. Lynch will seemingly take into account executing upon CVS’ vertically built-in care supply technique, we do anticipate her to take a contemporary have a look at the enterprise and have little worry of exploring new instructions. We consider Mr. Merlo’s legacy shall be having the braveness to attempt to reshape and higher make the most of the struggling retail pharmacy with the Aetna deal,” Hill famous.”CVS is within the early innings on delivering towards its imaginative and prescient of a vertically built-in healthcare providers firm with outsized shopper engagement,” the analyst concluded.To this finish, Hill charges CVS shares as a Purchase, and provides them a $101 worth goal, indicating his confidence in 35% development potential over the following months. (To look at Hill’s observe file, click on right here)General, CVS has 7 latest Purchase critiques and a couple of Holds, giving the inventory a Sturdy Purchase score from the analyst consensus. The common worth goal is $83.29, suggesting an 11% upside from the present share worth of $74.50. (See CVS inventory evaluation on TipRanks)Darling Substances (DAR)With the final inventory, we transfer from healthcare to the meals business. Darling Substances recycles the waste merchandise of the restaurant business and the animal-processing business – specifically, oils, fat, and grease – and manufactures usable meat and bone meals, yellow grease, and tallow. The corporate’s merchandise are utilized in pet meals, animal feeds, bioenergy, and fertilizers. Darling has delivered sturdy efficiency by way of 2020. The corporate’s quarterly earnings have held between $848 million and $852 million throughout the corona disaster, whereas earnings have been proven year-over-year good points in every quarter. The Q3 outcomes included 61 cents EPS on $850 million in high line revenues. DAR inventory has been rising steadily since final winter’s market crash, and is up ~77% year-to-date.That is one other new holding for Dalio and Bridgewater. Throughout Q3, the fund pulled the set off on 69,392 shares, which at the moment are price $3.46 million. Overlaying the inventory for Wolfe Analysis, 5-star analyst Sam Margolin is impressed by Darling’s mixture of cutting-edge renewable fuels and mature feed segments. “We price DAR Outperform due to its fast development within the Renewable Diesel phase (Diamond Inexperienced Diesel JV), supported by its feedstock/manufacturing benefit sourced largely from the bottom enterprise… DAR’s different segments are Meals and Feed substances, that are comparatively mature in comparison with Fuels. Whereas we don’t anticipate materials development in Meals and Feed, we observe that margins within the segments have been remarkably regular over latest years…”These feedback assist Margolin’s Outperform (i.e. Purchase) score, and his $67 worth goal implies 34% upside development subsequent yr. (To look at Margolin’s observe file, click on right here)Different analysts are on the identical web page. With 5 Buys and 1 Maintain acquired within the final three months, the phrase on the Road is that DAR is a Sturdy Purchase. Shares are presently priced at $49.87, and the $58.83 common worth goal suggests double-digit development of 18%. (See DAR inventory evaluation on TipRanks)To seek out good concepts for shares buying and selling at engaging valuations, go to TipRanks’ Greatest Shares to Purchase, a newly launched software that unites all of TipRanks’ fairness insights.Disclaimer: The opinions expressed on this article are solely these of the featured analysts. The content material is meant for use for informational functions solely. It is rather necessary to do your individual evaluation earlier than making any funding.